Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Romurtide

Romurtide

Romurtide structure

Romurtide 

structure
  • CAS No:

    78113-36-7

  • Formula:

    C43H78N6O13

  • Chemical Name:

    Romurtide

  • Synonyms:

    L-Lysine,N-(N-acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N6-(1-oxooctadecyl)-;L-Lysine,N2-[N2-[N-(N-acetylmuramoyl)-L-alanyl]-D-α-glutaminyl]-N6-(1-oxooctadecyl)-;N-(N-Acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N6-(1-oxooctadecyl)-L-lysine;Nα-Acetylmuramoyl-L-alanyl-D-isoglutaminyl-Nε-stearoyl-L-lysine;MDP-Lys(L 18);Muroctasin;Romurtide;Muroctasine;DJ 7041;Nopia;1: PN: WO2009033811 PAGE: 103 claimed protein;102604-65-9;124436-09-5;83175-69-3;94616-69-0

  • Categories:

    Biochemical Engineering  >  Polypeptide

Romurtide Basic Attributes

887.11

887.11

Characteristics

305

4.36240

1.21g/cm3

176-178 °C

1198.5ºC at 760 mmHg

678.6ºC

1.544

−20°C

LD50 in male, female mice, male, female rats, dogs (mg/kg): 436, 625, 761, 801, >200 s.c. (Ono)

D20 +24.9° (c = 1 in methanol)

Safety Information

3

OL5545000

P264, P270, P301+P312, P330, P501

H302

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|Aggregated GHS information provided by 39 companies from 2 notifications to the ECHA C&L Inventory.

Drug Information

Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)

MDP-Lys(L18)

Romurtide Use and Manufacturing

Methods of Manufacturing

Compound (I) is hydrolyzed with 60% acetic acid, and the protective group is removed to obtain compound (II), and then hydrogenated to obtain compound (III). Finally, it undergoes N-acylation reaction with active ester of octadecanoic acid to obtain romotide .

Uses

Anti-leukopenia drug. Suitable for leukopenia caused by radiotherapy.

Computed Properties

Molecular Weight:887.1
XLogP3:4.4
Hydrogen Bond Donor Count:10
Hydrogen Bond Acceptor Count:13
Rotatable Bond Count:35
Exact Mass:886.56268656
Monoisotopic Mass:886.56268656
Topological Polar Surface Area:305
Heavy Atom Count:62
Complexity:1360
Undefined Atom Stereocenter Count:9
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.